Ameriprise’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.3M | Buy |
132,603
+842
| +0.6% | +$155K | 0.01% | 1278 |
|
|
2025
Q4 | $23.2M | Sell |
131,761
-13,648
| -9% | -$2.23M | 0.01% | 1297 |
|
|
2025
Q3 | $20.4M | Buy |
145,409
+19,353
| +15% | +$2.62M | ﹤0.01% | 1381 |
|
|
2025
Q2 | $15.8M | Buy |
126,056
+23,505
| +23% | +$2.93M | ﹤0.01% | 1494 |
|
|
2025
Q1 | $14M | Sell |
102,551
-41,472
| -29% | -$5.93M | ﹤0.01% | 1540 |
|
|
2024
Q4 | $22M | Sell |
144,023
-1,006,463
| -87% | -$170M | 0.01% | 1271 |
|
|
2024
Q3 | $223M | Sell |
1,150,486
-299,519
| -21% | -$62.7M | 0.06% | 321 |
|
|
2024
Q2 | $336M | Buy |
1,450,005
+651,345
| +82% | +$142M | 0.09% | 232 |
|
|
2024
Q1 | $172M | Buy |
798,660
+596,173
| +294% | +$140M | 0.05% | 371 |
|
|
2023
Q4 | $52.4M | Sell |
202,487
-15,878
| -7% | -$3.9M | 0.02% | 755 |
|
|
2023
Q3 | $56.1M | Buy |
218,365
+19,638
| +10% | +$5.25M | 0.02% | 694 |
|
|
2023
Q2 | $56.6M | Sell |
198,727
-12,113
| -6% | -$3.61M | 0.02% | 711 |
|
|
2023
Q1 | $58.6M | Buy |
210,840
+86,919
| +70% | +$24.1M | 0.02% | 674 |
|
|
2022
Q4 | $34.3M | Buy |
123,921
+3,760
| +3% | +$1.06M | 0.01% | 902 |
|
|
2022
Q3 | $32.2M | Sell |
120,161
-581
| -0.5% | -$123K | 0.01% | 892 |
|
|
2022
Q2 | $24.5M | Sell |
120,742
-38,111
| -24% | -$7.79M | 0.01% | 1078 |
|
|
2022
Q1 | $32.8M | Sell |
158,853
-512,072
| -76% | -$111M | 0.01% | 1007 |
|
|
2021
Q4 | $160M | Buy |
670,925
+290,289
| +76% | +$74.6M | 0.04% | 418 |
|
|
2021
Q3 | $108M | Buy |
380,636
+191,227
| +101% | +$62.7M | 0.03% | 500 |
|
|
2021
Q2 | $65.6M | Sell |
189,409
-8,513
| -4% | -$2.58M | 0.02% | 676 |
|
|
2021
Q1 | $55.4M | Buy |
197,922
+98,756
| +100% | +$26.6M | 0.02% | 726 |
|
|
2020
Q4 | $24.3M | Sell |
99,166
-27,783
| -22% | -$7.17M | 0.01% | 1096 |
|
|
2020
Q3 | $36M | Buy |
126,949
+618
| +0.5% | +$172K | 0.01% | 773 |
|
|
2020
Q2 | $33.7M | Sell |
126,331
-54,918
| -30% | -$16.5M | 0.01% | 777 |
|
|
2020
Q1 | $57.3M | Sell |
181,249
-14,530
| -7% | -$4.41M | 0.03% | 498 |
|
|
2019
Q4 | $58.1M | Sell |
195,779
-25,443
| -12% | -$7.06M | 0.02% | 632 |
|
|
2019
Q3 | $51.5M | Sell |
221,222
-33,624
| -13% | -$7.83M | 0.02% | 641 |
|
|
2019
Q2 | $59.2M | Sell |
254,846
-327,010
| -56% | -$75.5M | 0.03% | 596 |
|
|
2019
Q1 | $137M | Sell |
581,856
-1,615,629
| -74% | -$509M | 0.06% | 313 |
|
|
2018
Q4 | $661M | Sell |
2,197,485
-588,438
| -21% | -$188M | 0.33% | 56 |
|
|
2018
Q3 | $1.06B | Buy |
2,785,923
+8,418
| +0.3% | +$2.9M | 0.37% | 52 |
|
|
2018
Q2 | $806M | Buy |
2,777,505
+171,656
| +7% | +$48.3M | 0.36% | 53 |
|
|
2018
Q1 | $714M | Sell |
2,605,849
-1,597
| -0.1% | -$496K | 0.32% | 65 |
|
|
2017
Q4 | $831M | Buy |
2,607,446
+298,052
| +13% | +$95.6M | 0.38% | 52 |
|
|
2017
Q3 | $723M | Buy |
2,309,394
+600,384
| +35% | +$178M | 0.34% | 61 |
|
|
2017
Q2 | $464M | Sell |
1,709,010
-164,519
| -9% | -$43.5M | 0.23% | 98 |
|
|
2017
Q1 | $512M | Sell |
1,873,529
-1,704,598
| -48% | -$482M | 0.27% | 80 |
|
|
2016
Q4 | $1.01B | Buy |
3,578,127
+53,173
| +2% | +$15.8M | 0.55% | 32 |
|
|
2016
Q3 | $1.1B | Sell |
3,524,954
-170,219
| -5% | -$50.4M | 0.62% | 30 |
|
|
2016
Q2 | $894M | Sell |
3,695,173
-401,978
| -10% | -$106M | 0.52% | 40 |
|
|
2016
Q1 | $1.07B | Buy |
4,097,151
+101,058
| +3% | +$26.7M | 0.64% | 29 |
|
|
2015
Q4 | $1.22B | Buy |
3,996,093
+186,764
| +5% | +$53.7M | 0.72% | 24 |
|
|
2015
Q3 | $1.11B | Buy |
3,809,329
+1,195,342
| +46% | +$395M | 0.69% | 24 |
|
|
2015
Q2 | $1.06B | Sell |
2,613,987
-621,522
| -19% | -$249M | 0.6% | 27 |
|
|
2015
Q1 | $1.37B | Buy |
3,235,509
+465,986
| +17% | +$184M | 0.78% | 16 |
|
|
2014
Q4 | $940M | Buy |
2,769,523
+188,035
| +7% | +$60.8M | 0.55% | 28 |
|
|
2014
Q3 | $854M | Sell |
2,581,488
-64
| -0% | -$21.1K | 0.51% | 32 |
|
|
2014
Q2 | $814M | Sell |
2,581,552
-60,572
| -2% | -$18.2M | 0.48% | 36 |
|
|
2014
Q1 | $808M | Buy |
2,642,124
+191,396
| +8% | +$60.8M | 0.49% | 33 |
|
|
2013
Q4 | $686M | Buy |
2,450,728
+288,758
| +13% | +$74.7M | 0.42% | 41 |
|
|
2013
Q3 | $521M | Sell |
2,161,970
-382,136
| -15% | -$85.5M | 0.34% | 55 |
|
|
2013
Q2 | $547M | Buy |
+2,544,106
| New | +$544M | 0.38% | 44 |
|
Other funds holding BIIB
VCM
VPM
Ameriprise's BIIB Position: Q1 2026 in Review
Ameriprise increased its Biogen (BIIB) stake by 0.64% in Q1 2026, buying an estimated $155K and bringing the position to 132,603 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #1278.
Ameriprise first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.37B in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Ameriprise held 132,603 shares of Biogen worth $24.3M as of Q1 2026.
- Ameriprise bought 842 Biogen shares in Q1 2026, an estimated $155K.
- Biogen made up 0.01% of Ameriprise's portfolio in Q1 2026, its #1278 holding.
- Ameriprise first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Biogen position peaked at $1.37B in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.